Hepatitis E and Pregnancy: An Unholy Alliance Unmasked from Kashmir, India.
Khuroo MS.
Viruses. 2021 Jul 9;13(7):1329. doi: 10.3390/v13071329.
Hepatitis E Virus Drug Development.
Kinast V, Burkard TL, Todt D, Steinmann E.
Viruses. 2019 May 28;11(6):485. doi: 10.3390/v11060485.
A Review of the Diagnosis and Management of Hepatitis E.
Kar P, Karna R.
Curr Treat Options Infect Dis. 2020;12(3):310-320. doi: 10.1007/s40506-020-00235-4. Epub 2020 Jul 17.
Antiviral strategies for hepatitis E virus.
Debing Y, Neyts J.
Antiviral Res. 2014 Feb;102:106-18. doi: 10.1016/j.antiviral.2013.12.005. Epub 2013 Dec 25.
Population-Based Estimates of Hepatitis E Virus-Associated Mortality in Bangladesh.
Paul RC, Gidding HF, Nazneen A, Banik KC, Sumon SA, Paul KK, Akram A, Uzzaman MS, Tejada-Strop A, Kamili S, Luby SP, Hayen A, Gurley ES.
J Infect Dis. 2025 Jul 11;231(6):e1129-e1137. doi: 10.1093/infdis/jiaf134.
Hepatitis E: when to treat and how to treat.
Abbas Z, Afzal R.
Antivir Ther. 2014;19(2):125-31. doi: 10.3851/IMP2705. Epub 2013 Nov 5.
Animal Models for Studying Congenital Transmission of Hepatitis E Virus.
Yadav KK, Kenney SP.
Microorganisms. 2023 Feb 28;11(3):618. doi: 10.3390/microorganisms11030618.
Current issues in the management of paediatric viral hepatitis.
Yeung LT, Roberts EA.
Liver Int. 2010 Jan;30(1):5-18. doi: 10.1111/j.1478-3231.2009.02145.x. Epub 2009 Oct 19.
Auranofin Inhibits Hepatitis E Virus Replication Via Reactive Oxygen Species.
Tiller K, Williams ST, Wang B, Tian D, Meng XJ, Weger-Lucarelli J.
bioRxiv [Preprint]. 2025 May 2:2025.05.02.651833. doi: 10.1101/2025.05.02.651833.
The hepatitis E virus ORF1 hypervariable region confers partial cyclophilin dependency.
Buchanan FJT, Chen S, Harris M, Herod MR.
J Gen Virol. 2023 Nov;104(11):001919. doi: 10.1099/jgv.0.001919.
